Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Laboratories (CLB) Operating Expenses (2022 - 2026)

Core Laboratories filings provide 5 years of Operating Expenses readings, the most recent being $18.3 million for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 6.0% to $18.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $60.8 million, a 8.58% increase, with the full-year FY2025 number at $59.7 million, up 10.15% from a year prior.
  • Operating Expenses hit $18.3 million in Q1 2026 for Core Laboratories, up from $14.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $18.3 million in Q1 2026 to a low of $3.7 million in Q4 2023.
  • Median Operating Expenses over the past 5 years was $12.4 million (2024), compared with a mean of $10.0 million.
  • Biggest five-year swings in Operating Expenses: fell 9.12% in 2023 and later soared 293.6% in 2024.
  • Core Laboratories' Operating Expenses stood at $3.9 million in 2022, then decreased by 4.05% to $3.7 million in 2023, then skyrocketed by 236.89% to $12.6 million in 2024, then grew by 12.82% to $14.2 million in 2025, then rose by 28.35% to $18.3 million in 2026.
  • The last three reported values for Operating Expenses were $18.3 million (Q1 2026), $14.2 million (Q4 2025), and $14.2 million (Q3 2025) per Business Quant data.